Researchers at Michigan State University and the University of Michigan have created a handheld device called Gene-Z that they say could aid in cancer diagnosis in underserved areas. The device, which features a microfluidic chip, allows providers to analyze blood samples onsite and transmits the readings to an Android tablet, iPad or iPod Touch.
Handheld device holds promise for onsite cancer diagnosis
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||